Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7576714rdf:typepubmed:Citationlld:pubmed
pubmed-article:7576714lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7576714lifeskim:mentionsumls-concept:C0020517lld:lifeskim
pubmed-article:7576714lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:7576714lifeskim:mentionsumls-concept:C1155046lld:lifeskim
pubmed-article:7576714lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:7576714lifeskim:mentionsumls-concept:C0559469lld:lifeskim
pubmed-article:7576714lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:7576714lifeskim:mentionsumls-concept:C0443288lld:lifeskim
pubmed-article:7576714pubmed:issue2lld:pubmed
pubmed-article:7576714pubmed:dateCreated1995-12-26lld:pubmed
pubmed-article:7576714pubmed:abstractTextWe investigated the synergistic effect of anti-HLA class II monoclonal antibodies on proliferative responses to ovalbumin (OA) of T cell line (TCL) cells from five hen's-egg-sensitive patients. Among the five patients, the proliferation of the TCL cells from two patients with AD who have a low immune reaction was restored by the anti-HLA-DQ monoclonal antibodies, and the proliferation of the TCL cells from the other three patients was inhibited by the anti-HLA-DP monoclonal antibodies. These results suggest that a component of the T cell repertoire reactive with OA in hen's-egg-sensitive patients may be restricted by HLA-DP molecules. Furthermore, in hen's-egg-sensitive patients with AD who have a low immune reaction, low responsiveness may be regulated by HLA-DQ molecules.lld:pubmed
pubmed-article:7576714pubmed:languageenglld:pubmed
pubmed-article:7576714pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7576714pubmed:citationSubsetIMlld:pubmed
pubmed-article:7576714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7576714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7576714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7576714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7576714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7576714pubmed:statusMEDLINElld:pubmed
pubmed-article:7576714pubmed:issn0254-9670lld:pubmed
pubmed-article:7576714pubmed:authorpubmed-author:KobayashiYYlld:pubmed
pubmed-article:7576714pubmed:authorpubmed-author:KondoNNlld:pubmed
pubmed-article:7576714pubmed:authorpubmed-author:FukutomeSSlld:pubmed
pubmed-article:7576714pubmed:authorpubmed-author:NishidaTTlld:pubmed
pubmed-article:7576714pubmed:authorpubmed-author:OriiTTlld:pubmed
pubmed-article:7576714pubmed:authorpubmed-author:AgataHHlld:pubmed
pubmed-article:7576714pubmed:authorpubmed-author:ShinbaraMMlld:pubmed
pubmed-article:7576714pubmed:issnTypePrintlld:pubmed
pubmed-article:7576714pubmed:volume12lld:pubmed
pubmed-article:7576714pubmed:ownerNLMlld:pubmed
pubmed-article:7576714pubmed:authorsCompleteYlld:pubmed
pubmed-article:7576714pubmed:pagination103-10lld:pubmed
pubmed-article:7576714pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:meshHeadingpubmed-meshheading:7576714-...lld:pubmed
pubmed-article:7576714pubmed:year1995lld:pubmed
pubmed-article:7576714pubmed:articleTitleT cell proliferation restricted by HLA class II molecules in patients with hen's egg allergy.lld:pubmed
pubmed-article:7576714pubmed:affiliationDepartment of Pediatrics, Gifu University School of Medicine, Japan.lld:pubmed
pubmed-article:7576714pubmed:publicationTypeJournal Articlelld:pubmed